Clinical Performance of Two Different Restorative Materials in Restoring Class II Cavities of Primary Molars
Clinical Performance of a Flowable Giomer Versus a Highly Viscous Glass-ionomer Cement in Restoring Class II Cavities of Primary Molars: A Randomized Clinical Trial
1 other identifier
interventional
124
1 country
1
Brief Summary
The aim of the present study is to assess Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) in class II cavities of primary molars regarding the following objectives: The primary objective To evaluate and compare the clinical performance of Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) in restoring class II cavities of primary molars after 3,6, and 12 months. The secondary objective To assess the effect of different independent variables on the treatment outcome of the experimental restorative materials. Research question: Is there a difference in the clinical performance between flowable giomers and highly viscous glass ionomer in restoring class II cavities of primary molars? Null Hypothesis There is no difference in the clinical performance between Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) after one year of follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2022
CompletedFirst Submitted
Initial submission to the registry
August 11, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedSeptember 13, 2023
September 1, 2023
1.4 years
August 11, 2023
September 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The clinical performance of Flowable Giomer Beautifil Flow Plus X (Shofu Dental Corporation, Japan) and Glass-hybrid-added HVGIC, Equia Forte (GC Corporation, Tokyo, Japan) in restoring class II cavities of primary molars
The restorations will be evaluated using the FDI criteria having esthetic, functional, and biological properties
12 months
Secondary Outcomes (1)
The effect of different independent variables on the treatment outcome of the experimental restorative materials.
12 months
Study Arms (2)
Flowable Giomer Beautifil flow plus x
EXPERIMENTALinjectable flowable restorative material
Glass-hybrid-added HVGIC Equia Forte
ACTIVE COMPARATORGlass-hybrid-added Highly viscous glass ionomer cement
Interventions
removal of proximal caries of primary molars and restoration of the cavities prepared by beautifil flow plus x
removal of proximal caries of primary molars and restoration of the cavities prepared by equia forte
Eligibility Criteria
You may qualify if:
- to 8 years old medically free children.
- Cooperative children classified as class 3 or 4 based on Frankel et al. classification
- Children who had at least one active dentinal carious lesion on proximal surface of primary molars
- Primary molars with active dentinal carious lesion on their proximal surface score 4, 5 using ICDAS.
- Primary molars with proximal carious lesion extended to outer and middle third of dentin scored D1and D2 that will be detected by bitewing radiograph.
- Simple or compound class II cavities be present
- The antagonist and the adjacent tooth should be present
- Primary molar should have at least 2/3 of the root present
You may not qualify if:
- Refusal of the parents to sign the informed consent
- Presence of deep bite or any pictures of malocclusion and any parafunctional habits.
- Presence of any unprovoked pain, pulp exposure,clinical swelling, abscess or fistula.
- Presence of any physiological or pathological mobility.
- Very deep subgingival cavities
- Teeth with congenitally missing successor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of dentistry ain shams university
Cairo, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Emad
faculty of dentistry ain shams university
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer at the Pediatric Dentistry and Dental Public Health Department-Faculty of Dentistry
Study Record Dates
First Submitted
August 11, 2023
First Posted
August 21, 2023
Study Start
December 30, 2022
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share